KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study.
about
Deregulation of the miR-16-KRAS axis promotes colorectal cancer.KRAS exon 2 codon 13 mutation is associated with a better prognosis than codon 12 mutation following lung metastasectomy in colorectal cancer.Perioperative bevacizumab improves survival following lung metastasectomy for colorectal cancer in patients harbouring v-Ki-ras2 Kirsten rat sarcoma viral oncogene homologue exon 2 codon 12 mutations†.
P2860
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
KRAS Exon 2 Mutations as Progn ...... e: A Mono-Institutional Study.
@en
KRAS Exon 2 Mutations as Progn ...... e: A Mono-Institutional Study.
@nl
type
label
KRAS Exon 2 Mutations as Progn ...... e: A Mono-Institutional Study.
@en
KRAS Exon 2 Mutations as Progn ...... e: A Mono-Institutional Study.
@nl
prefLabel
KRAS Exon 2 Mutations as Progn ...... e: A Mono-Institutional Study.
@en
KRAS Exon 2 Mutations as Progn ...... e: A Mono-Institutional Study.
@nl
P2093
P2860
P50
P1476
KRAS Exon 2 Mutations as Progn ...... e: A Mono-Institutional Study.
@en
P2093
Alessandra Cassano
Antonia Strippoli
Carlo Barone
Eleonora Cerchiaro
Giovanni Schinzari
Michele Basso
Sara Capodimonti
P2860
P2888
P356
10.1007/S40291-015-0178-8
P577
2015-11-26T00:00:00Z